Insights and News
4G Clinical Raises $230M to Expand its RTSM Global Reach, Product Capabilities
June 29, 2021 Fierce Biotech
Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg?
Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg?
Direct-to-Patient (DtP) in Review – What Would We Have Done Differently if We Knew COVID-19 was Coming?
4G Clinical Named to Fast Company’s Second Annual List Of The 100 Best Workplaces for Innovators
4G Clinical joins Google, Dell, Diageo, Alibaba, Etsy, Nestle, and many others.
5 Supply Chain Impacts Resulting from Master Protocol Amendments – And How to Prepare
3 Simple Steps to Manage Multiple Protocol Versions in a Single Study
Managing protocol versions at the site level and the broader protocol amendment at th...
Master Protocol Studies – A Map to an Unknown Destination
Society for Clinical Research Sites (SCRS): Podcast with 4G's Neta Bendelac on Direct-to-Patient Trials
This podcast was originally hosted by Society for Clinical Research Sites (SCRS). To ...
Clinical Research News: Q&A with 4G’s Barry Moore
Trial Disruptions In Uncertain Times: Q&A With 4G’s Barry Moore By Deborah Borfit...
The Need for Virtual Trials: A Site’s Perspective
The Need for Virtual Trials: A Site’s Perspective “No one knows where the COVID-19 pa...
4G Clinical Launches Direct-to-Patient (DtP) Clinical Trial Platform
Prancer RTSM™’s DtP Functionality Enables Clinical Trial Continuity during the COVID-...